COVID-19 IgM/IgG Rapid Test

Coronavirus Disease 2019, or COVID-19, is a novel respiratory disease that has characterized as a pandemic by the World Health Organization.

On March 16, 2020, the FDA updated its Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency to included guidance for serology tests that identify antibodies (e.g., IgM, IgG) to SARS-CoV-2 from clinical specimens; allowing healthcare entities to perform testing at the point-of-care.

kit-rapid

Rapid screening of individuals with this virus is vital in addressing this escalating public health issue. Recent studies suggest that a high percentage of patients show no clinical symptoms of the SARS-CoV-2 virus, thus screening patients is vitally important.

Features & Benefits

BitCare Rapid IgM-IgG Combined Antibody Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies of the novel coronavirus in human serum, plasma or whole blood in vitro.

Precise

  • Works with whole blood, serum, & plasma
  • Tests for both IgM and IgG antibodies
  •  Validated using PCR

Fast

  • 10-15 minutes per test
  • Intuitive visual interpretation
  • No special equipment needed

How It Works

Collect
blood sample

rapid-icon-2

Add blood sample
to sample well

rapid-icon-3

Place 2-3 drops of
buffer in sample well

Read results after
15 minutes

Results

tests

Applications

The COVID-19 IgM/IgG Rapid Test is ideally suited for hospitals, clinics, care facilities, laboratories, and mobile clinics. The test can potentially be effectively deployed in schools, airports, seaports, businesses, community centers, senior living, nursing homes, care facilities, etc., giving it the potential to become a compelling force in the fight against this pandemic.

General Population Screening

  • Allows rapid examination and diagnosis near the point of care

Hospitals, Physician Offices, Laboratories

  • Can screen carriers who are asymptomatic
  • Can determine if the patient recently affected by the virus, even if the virus is no longer present

NOTE: Updated USFDA guidance issued on March 16, 2020, allows the distribution of this product for diagnostic use in laboratories or by healthcare workers at the point-of-care. The updated policy can be viewed by clicking here. Please see FAQ’s below for more detailed information.

COVID-19 IgM/IgG Rapid Test

COVID-19 Testing: PCR Versus Serology Testing, Explained

There are two types of tests available for COVID-19 that can detect whether a person had it in the past (serology testing, which tests for antibodies against SARS-CoV-2, the virus that causes COVID-19), or whether they have it in the present (polymerase chain reaction (PCR) testing, which tests for active infection). This document is designed to explain the differences between PCR and serology testing, and when one test might be used over another.

Testimonials

Deserves recognition

THANKS, Again, many thanks. Your company is truly doing a service. Deserves recognition
Best

– Prof. Dantu

You guys have been great!

“You guys have been great, I’m excited to have found a group that can fit what we needed. We looked for a while”

– Matt

Thank you so much

“I got it thank you so much. I can return to work… “

– Ana

Great experience!

Had great experience with BitCare few weeks back for COVID testing. Thanks to team for expedited results with their personal touch.

– Ajay